Levels of Plasma Homocysteine in Obese Women Subjects Homocysteine and Obesity

被引:2
作者
YIlmaz, Vural Taner [1 ]
Coban, Erkan [2 ]
Avci, Ali Berkant [3 ]
Yilmaz, Fatih [1 ]
Cetinkaya, Ramazan [1 ]
机构
[1] Akdeniz Univ, Fac Med, Dept Internal Med, Div Nephrol, Antalya, Turkey
[2] Akdeniz Univ, Fac Med, Dept Internal Med, Antalya, Turkey
[3] Akdeniz Univ, Fac Med, Dept Internal Med, Div Rhumatol, Antalya, Turkey
来源
TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL | 2014年 / 23卷 / 02期
关键词
Obesity; Homocysteine; Body mass index; Cardiovascular risk;
D O I
10.5262/tndt.2014.1002.03
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: An increased homocysteine level is an independent risk factor for vascular diseases. The present study was designed to evaluate plasma homocysteine levels in obese women compared with non-obese healthy women. MATERIAL and METHODS: We selected 55 obese women (mean age 47.2 +/- 9.2 years) having a body mass index >= 30 kg/m(2) and 50 non-obese healthy women matched for age (mean age 46.3 +/- 9.5 years) who attended our outpatients clinic. We measured levels of homocysteine in obese and nonobese groups. RESULTS: No significant difference was observed between obese and non-obese control groups regarding the homocysteine levels (10.3 +/- 3.5 mu mol/l vs. 10.1 +/- 3.8 mu mol/l, p>0.05). In this selected study population as a whole, the correlation between homocysteine levels and body mass index did not attain statistical significance (r=0.12, p>0.05). CONCLUSION: We found that homocysteine levels were comparable between middle-aged obese and non-obese women. Our data may suggest that increased cardiovascular risk in obese women is probably not related to the homocysteine level.
引用
收藏
页码:91 / 94
页数:4
相关论文
共 26 条
[1]  
Akoglu Bora, 2006, Exp Clin Transplant, V4, P462
[2]   Homocysteine and arteriosclerosis - Subclinical and clinical disease associations [J].
Bostom, AG ;
Selhub, J .
CIRCULATION, 1999, 99 (18) :2361-2363
[3]  
Brasileiro R. S., 2005, Nutr. Hosp., V20, P313
[4]   American Heart Association call to action: Obesity as a major risk factor for coronary heart disease [J].
Eckel, RH ;
Krauss, RM .
CIRCULATION, 1998, 97 (21) :2099-2100
[5]   Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence [J].
Eikelboom, JW ;
Lonn, E ;
Genest, J ;
Hankey, G ;
Yusuf, S .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (05) :363-375
[6]   Insulin sensitivity and plasma homocysteine concentrations in nondiabetic obese and normal weight subjects [J].
Fonseca, VA ;
Fink, LM ;
Kern, PA .
ATHEROSCLEROSIS, 2003, 167 (01) :105-109
[7]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[8]   Plasma homocysteine as a risk factor for vascular disease - The European concerted action project [J].
Graham, IM ;
Daly, LE ;
Refsum, HM ;
Robinson, K ;
Brattstrom, LE ;
Ueland, PM ;
PalmaReis, RJ ;
Boers, GHJ ;
Sheahan, RG ;
Israelsson, B ;
Uiterwaal, CS ;
Meleady, R ;
McMaster, D ;
Verhoef, P ;
Witteman, J ;
Rubba, P ;
Bellet, H ;
Wautrecht, JC ;
deValk, HW ;
Luis, ACS ;
ParrotRoulaud, FM ;
Tan, KS ;
Higgins, I ;
Garcon, D ;
Medrano, MJ ;
Candito, M ;
Evans, AE ;
Andria, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1775-1781
[9]   The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis [J].
Guh, Daphne P. ;
Zhang, Wei ;
Bansback, Nick ;
Amarsi, Zubin ;
Birmingham, C. Laird ;
Anis, Aslam H. .
BMC PUBLIC HEALTH, 2009, 9
[10]   Hyperhomocysteinemia, vascular function and atherosclerosis: Effects of vitamins [J].
Haynes, WG .
CARDIOVASCULAR DRUGS AND THERAPY, 2002, 16 (05) :391-399